Bioengineered Stromal Cell-Derived Factor-1α Analogue Delivered as an Angiogenic Therapy Significantly Restores Viscoelastic Material Properties of Infarcted Cardiac Muscle

Ischemic heart disease is a major health problem worldwide, and current therapies fail to address microrevascularization. Previously, our group demonstrated that the sustained release of novel engineered stromal cell-derived factor 1-α analogue (ESA) limits infarct spreading, collagen deposition, im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Biomech Eng
Hauptverfasser: Trubelja, Alen, MacArthur, John W., Sarver, Joseph J., Cohen, Jeffrey E., Hung, George, Shudo, Yasuhiro, Fairman, Alexander S., Patel, Jay, Edwards, Bryan B., Damrauer, Scott M., Hiesinger, William, Atluri, Pavan, Joseph Woo, Y.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Mechanical Engineers 2014
Schlagworte:
Technical Brief
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307777/
https://ncbi.nlm.nih.gov/pubmed/24860865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1115/1.4027731
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge